Labo EuromedisFRA:61R +0.42%61 Days Inventory is 86.56 as of Dec. 2025, which is 26% below its 10-year median of 117.16. GuruFocus rates FRA:61R with a GF Score™ of 61/100 and a GF Value™ of €4.37. The stock has 6 warning signs investors should review. Among 115 Medical Distribution companies, Labo Euromedis ranks worse than 80.87% on this metric.
The historical rank and industry rank for Labo Euromedis's Days Inventory or its related term are showing as below:
FRA:61R'
s Days Inventory Range Over the Past 10 Years
Min: 61.94 Med: 117.16 Max: 125.41
Current: 108.57
During the past 13 years, Labo Euromedis's highest Days Inventory was 125.41. The lowest was 61.94. And the median was 117.16.
FRA:61R's Days Inventory is ranked worse than 80.87% of 115
companies
in the Medical Distribution industry
Industry Median: 57.26
vs FRA:61R: 108.57
Labo Euromedis's Days Inventory
declined
from Dec. 2024 (89.97) to Dec. 2025 (86.56).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Labo Euromedis's Inventory Turnover for the
six
months ended in Dec. 2025 was 2.11.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Labo Euromedis's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.50.
Labo Euromedis (FRA:61R) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Labo Euromedis's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Labo Euromedis's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Labo Euromedis Days Inventory Related Terms
Labo Euromedis Days Inventory Historical Data
* Premium members only.
The historical data trend for Labo Euromedis's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:61R vs MCK, CAH, COR: Days Inventory Comparison
For the Medical Distribution subindustry, Labo Euromedis's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Labo Euromedis Days Inventory vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Labo Euromedis's Days Inventory distribution charts can be found below:
* The bar in red indicates where Labo Euromedis's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Labo Euromedis (FRA:61R) has a Days Inventory of 86.56 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Labo Euromedis and its competitors. This is 26% below median its historical median of 117.16. Over the past decade, Labo Euromedis' Days Inventory has ranged from 61.94 to 125.41. According to the industry distribution chart, Labo Euromedis ranks #93 out of 115 companies in the Medical Distribution industry, placing it in the top 80.9%.
Is Labo Euromedis' Days Inventory too high?
Labo Euromedis' current Days Inventory of 86.56 is 26% below median its 10-year median of 117.16. Over the past 10 years, this metric has ranged from a low of 61.94 to a high of 125.41. The Medical Distribution industry median Days Inventory is 57.26. Labo Euromedis' value of 86.56 is 51.2% above this industry median. Based on the distribution chart, Labo Euromedis ranks #93 out of 115 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Labo Euromedis has a GF Score™ of 61/100, reflecting its overall financial health beyond just this single metric.
How does Labo Euromedis' Days Inventory compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Labo Euromedis ranks #93 out of 115 companies for Days Inventory. This places Labo Euromedis in the lower half of its industry. The industry median Days Inventory is 57.26. Labo Euromedis' value of 86.56 is 51.2% above this benchmark. Historically, Labo Euromedis' own Days Inventory has ranged from 61.94 to 125.41 over the past decade. While the company's 10-year median is 117.16 vs. the industry median of 57.26, Labo Euromedis has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Distribution company?
The median Days Inventory among Medical Distribution companies is 57.26, based on 115 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Labo Euromedis's current Days Inventory of 86.56 is 51.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Labo Euromedis and its competitors. For the Medical Distribution industry, the median Days Inventory is 57.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Labo Euromedis's current Days Inventory is 86.56, which is 26% below median its own 10-year median of 117.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labo Euromedis stock overvalued right now?
Labo Euromedis (FRA:61R) has a current Days Inventory of 86.56. The stock's GF Value™ is €4.37, compared to a current price of €4.76 — trading 8.9% above its estimated fair value. The current Days Inventory is 86.56, which is 26% below median its 10-year median of 117.16 and 51.2% above the Medical Distribution industry median of 57.26. Labo Euromedis' overall GF Score™ is 61/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Labo Euromedis (FRA:61R), the current Days Inventory is 86.56 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Labo Euromedis (FRA:61R) Overvalued in 2026?
Based on GuruFocus' analysis, Labo Euromedis stock appears to be overvalued.
The current stock price of €4.76 is trading 8.9% above its estimated GF Value™ of €4.37.
Key valuation signals for FRA:61R:
Days Inventory: 86.56 (26% below median its 10-year median of 117.16)
GF Value™: €4.37 vs. price of €4.76 (8.9% above fair value)
Industry Position: 51.2% above the Medical Distribution median (#93 of 115)
No single metric tells the full story. See the FRA:61R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Labo Euromedis is engaged in medical devices. It is engaged in the design, manufacture, rental and export of medical and surgical equipment and products.
61GF Score
Get the complete analysis for FRA:61R
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:61R has been successfully added to your 
